Medical News

RSS

New data on Cladribine Tablets presented at AAN annual meeting

EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis were presented at the 62nd Annual Meeting of the American Academy of Neurology.

17 Apr 2010

Obama extends hospital visitation rights, medical decisions, to gays and other non-family members

The Washington Post: "President Obama mandated Thursday that nearly all hospitals extend visitation rights to the partners of gay men and lesbians and respect patients' choices about who may make critical health-care decisions for them. ... The president directed the Department of Health and Human Services to prohibit discrimination in hospital visitation in a memo that was e-mailed to reporters ... while he was at a fundraiser in Miami."

17 Apr 2010

AMD LASERS introduces disposable tips for dental laser procedures

AMD LASERS, LLC proudly announces that effective April 1, 2010, dental practitioners now have the option of using disposable tips or a strippable fiber with the number 1 selling dental lasers in the world - Picasso and Picasso Lite.

From AMD Lasers 17 Apr 2010

70% of COPD patients under-diagnosed due to lack of disease knowledge

"It is high time to demystify COPD in order to better explain the issues and help people who suffer from this disease," says Dr. Jean Bourbeau, Director of the Respiratory, Epidemiology and Clinical Research Unit at the Montreal Chest Institute of the MUHC, and lead investigator of CanCOLD along with Dr. Wan Tan of The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia.

17 Apr 2010

Massachusetts Senate stiffens penalties for assaulting nurses and health care workers

The Massachusetts Senate cast a unanimous vote today to pass legislation which will stiffen the penalties of those who assault nurses and other health care workers, one of a series of measures the state's nurses are proposing to address the growing problem of workplace violence in health care settings. The House of Representatives had passed the bill in March.

17 Apr 2010

Mass. health official quits, rumors say he's Washington bound

"Jon Kingsdale, head of the quasi-state agency that oversees Massachusetts' landmark health law, is stepping down June 4, Governor Deval Patrick said yesterday."

17 Apr 2010

Treatment with high dose UDCA no more effective for NASH: German study

Results of a German study presented today at the International Liver CongressTM 2010, the Annual Meeting of the European Association for the Study of Liver in Vienna, Austria, have shown that overall, treatment with high dose (23-28mg/kg/d) ursodeoxycholic acid is no more effective than placebo in the treatment of non-alcoholic steatohepatitis, the most advanced form of non-alcoholic liver disease associated with cirrhosis of the liver.

17 Apr 2010

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

Tikcro Technologies Ltd. today reported results for the fourth quarter and year ended December 31, 2009.

17 Apr 2010

APiX View Detection Kits available for ultra-sensitive chromogenic detection of protein microarrays

Gentel Biosciences, a leader in proteomics discovery tools, today announced the availability of the APiX View Detection Kits for ultra-sensitive chromogenic detection of protein microarrays, including reverse phase protein such as SomaPlex arrays from Protein Biotechnologies.

17 Apr 2010

Sen. Rockefeller casts 'a watchful eye' on insurers' accounting practices

Dow Jones Newswires/ NASDAQ: "A report released Thursday by the chairman of the U.S. Senate Commerce, Science and Transportation Committee cautioned against health insurers using 'creative accounting' to meet new requirements for the amount of premium dollars they spend on patient care." The requirement is that insurers spend 80 percent of the premiums they collect on patient care for small group and individual plans, and 85 percent for large group plans (Brin, 4/15).

17 Apr 2010

Strativa Pharmaceuticals: Oravig buccal tablets receive FDA approval for OPC

Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis, more commonly known as thrush, in adults and children age 16 and older.

17 Apr 2010

NPS Pharmaceuticals prices 9,000,000 shares of common stock at $5.50 per share

NPS Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $5.50 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $46.2 million.

17 Apr 2010

Knopp Neurosciences to initiate Phase 3 studies of KNS-760704 in AL

In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.

17 Apr 2010

Health law help for those with preexisting conditions; IRS to enforce individual mandate through refunds

"Starting in July, a special high-risk pool will offer coverage to uninsured people with pre-existing health conditions at a cost similar to what everyone else pays. It's the first test of whether the administration can deliver on Obama's vision within the budget Congress set. But some vulnerable patients are probably going to feel a little cheated."

17 Apr 2010

Health sciences professionals meet to discuss public health care issues

Members of the Health Sciences Association, the health care union that represents health sciences professionals who deliver diagnosis, treatment and recovery in BC's hospitals and communities, is meeting this weekend at its 39th annual convention in Vancouver.

17 Apr 2010

States gear up for implementation, others continue to fight overhaul

Chillicothe Gazette/Gannett: "The spotlight on health care has shifted from the federal government, which wrote the recently passed overhaul legislation, to states, which will be in charge of much of the implementation. States will oversee the expansion of Medicaid, enforce the new insurance reforms and set up and run the new insurance 'exchanges' for small businesses and people who aren't offered coverage through an employer.

17 Apr 2010

RegeneRx Biopharmaceuticals proposes common stock public offering

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced today that it intends to offer units consisting of shares of its common stock and warrants to purchase shares of its common stock in a public offering.

17 Apr 2010

Researchers study effectiveness of TeleCare in keeping individuals healthy

Like the bleeps of an alarm clock, TeleCare, a home monitoring device, gives the chronically ill a wake-up call: "It's time to take your vitals."

17 Apr 2010

Akela to terminate lease payment agreement

Akela a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract pharmaceutical development and manufacturing business, today announced that it has reached agreement with HEP Davis Spring, L.P. to terminate its lease located at 9825 Spectrum Drive, Austin, Texas, eliminating $14,500,000 in future lease payment obligations to the Company.

17 Apr 2010

Federal cancer research is 'at a breaking point,' IOM study finds

Bloomberg: "The government's cancer research network is 'approaching a state of crisis' as waste and inefficiency cause 40 percent of late-stage trials it funds to be abandoned before completion, according to a report released yesterday. The government-funded National Cancer Institute's clinical trials group isn't able to effectively study the benefits of new and current treatments, according to the analysis by the Institute of Medicine.

17 Apr 2010